Literature DB >> 24215175

Vision-related quality of life tends to be more severely impaired in patients with dysthyroid optic neuropathy.

Yi Du1, Huijing Ye, Kaijun Li, Xin Xiao, Rongxin Chen, Jian-Feng He, Huasheng Yang.   

Abstract

PURPOSE: Dysthyroid optic neuropathy (DON) is the most severe condition in thyroid eye disease (TED); however, no study has been conducted to assess quality of life in these patients to date. The aim of this study was to evaluate vision-related quality of life in TED patients with DON using a Chinese version of the 25-item National Eye Institute Visual Function Questionnaire (CHI-VFQ-25).
METHODS: The CHI-VFQ-25 scores were compared for 23 TED patients with DON and 13 TED patients without DON. The correlations between the clinical characteristics and subscale scores on the CHI-VFQ-25 and the floor and ceiling effects of the CHI-VFQ-25 were also assessed.
RESULTS: Patients with DON scored significantly lower than patients without DON on the CHI-VFQ-25 (composite score: 54 versus 77, respectively, p = 0.001). Many subscales were significantly correlated with the severity and activity of the disease (p < 0.05). In patients with DON, no floor effects were found, and ceiling effects were only observed for Color vision, Peripheral vision and Social function. Role limitations and Mental health were the lowest scores in all the subscales.
CONCLUSIONS: The current study showed that vision-related quality of life tended to be more severely impaired in TED patients with DON than in patients without DON. The CHI-VFQ-25 may be a promising tool to estimate the benefits of interventions in patients with DON.

Entities:  

Mesh:

Year:  2013        PMID: 24215175     DOI: 10.3109/02713683.2013.848901

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

1.  Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.

Authors:  K A Ponto; T Diana; H Binder; N Matheis; S Pitz; N Pfeiffer; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2015-03-04       Impact factor: 4.256

2.  Frequency of IL-10-producing regulatory B cells associated with disease activity in thyroid-associated orbitopathy.

Authors:  Yun-Gang Ding; Guo Chen; Qian Li; Xiao-Feng Wen; Lai Wei; Hua-Sheng Yang
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

3.  Proposal for Standardization of Primary and Secondary Outcomes in Patients with Active, Moderate-to-Severe Graves' Orbitopathy.

Authors:  Luigi Bartalena; Wilmar M Wiersinga
Journal:  Eur Thyroid J       Date:  2020-09-21

4.  Vision-Related Quality of Life and Association Between Retinal Parameters in Patients with Non-Arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Yufang Su; Gang Bai; Hong Tian; Song Zhang; Yingru Liu; Guisen Zhang; Lei Liu; Kang Chen
Journal:  Int J Gen Med       Date:  2022-05-24

5.  Risk factors for idiopathic optic neuritis recurrence.

Authors:  Yi Du; Jing-Jing Li; Yu-Jiao Zhang; Kaijun Li; Jian-Feng He
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

6.  Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.

Authors:  Alexander D Blandford; Dalia Zhang; Rao V Chundury; Julian D Perry
Journal:  Expert Rev Ophthalmol       Date:  2017-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.